Neurogenic overactive bladder: focus on cognitive function
- Авторлар: Korshunova E.S1,2,3, Korshunov M.N2, Nuzhnyi E.P1, Zakroyshchikova I.V1, Zabirova A.K.1, Korshunov D.M3, Suponeva N.A1, Darenkov S.P2
-
Мекемелер:
- FGBNU Research Center of Neurology
- FGBU “Central state medical academy” of Administrative Directorate of the President of Russian Federation
- A.I. Evdokimov’s Moscow State University of Medicine and Dentistry
- Шығарылым: № 5 (2021)
- Беттер: 35-40
- Бөлім: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/312694
- DOI: https://doi.org/10.18565/urology.2021.5.35-40
- ID: 312694
Дәйексөз келтіру
Аннотация
Толық мәтін
Авторлар туралы
E. Korshunova
FGBNU Research Center of Neurology; FGBU “Central state medical academy” of Administrative Directorate of the President of Russian Federation; A.I. Evdokimov’s Moscow State University of Medicine and Dentistry
Email: e_korshunova@mail.ru
Ph.D., associate professor
M. Korshunov
FGBU “Central state medical academy” of Administrative Directorate of the President of Russian FederationPhD, associate professor
E. Nuzhnyi
FGBNU Research Center of NeurologyPh.D.
I. Zakroyshchikova
FGBNU Research Center of NeurologyPh.D.
A. Zabirova
FGBNU Research Center of NeurologyPh.D. student
D. Korshunov
A.I. Evdokimov’s Moscow State University of Medicine and Dentistrystudent
N. Suponeva
FGBNU Research Center of NeurologyPh.D., MD, Professor
S. Darenkov
FGBU “Central state medical academy” of Administrative Directorate of the President of Russian Federationh.D., MD, Professor, Head of the Department of Urology
Әдебиет тізімі
- Филиппова Е.С., Борзунов И.В., Баженов И.В. Дисфункция нижних мочевыводящих путей у неврологических больных. Уральский медицинский журнал. 2019;5(173):169-172. doi: 10.25694/URMJ.2019.05.43
- Коршунова Е.С., Коршунов М.Н., Даренков С.П. Нейрогенный и идиопатический гиперактивный мочевой пузырь: камни преткновения. Consilium Medicum 2019;21(7):53-57. doi: 10.26442/20751753.2019.7.190384
- Захаров В.В., Яхно Н.Н. Когнитивные расстройства в пожилом и старческом возрасте: Методическое пособие для врачей. М., 2005
- Andersson K.E., Cardozo L., Cruz F., Lee K.S., Sahai A., Wein A.J. Pharmacological treatment of urinary incontinence. In: Abrams P, Cardozo L, Wagg A, Wein A, editors. Incontinence 6th edition. 2017:805-957. doi: 10.1046/j.1464-410x.1999.00397.x.
- Kay G.G., Granville L.J. Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly Clin Ther. 2005;27(1):127-138. doi: 10.1016/j.clinthera.2005.01.00.
- Ziad S. Nasreddine, Natalie A. Phillips, Valerie Bedirian, Simon Charbonneau, Victor Whitehead.The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment (англ.). Journal of the American Geriatrics Society. 2005;53(4):695-699. ISSN 1532-5415. doi: 10.1111/j.1532-5415.2005.53221.x.
- Rudy D., Cline K., Harris R., Goldberg K., Dmochowski R. Time to onset of improvement in symptoms of overactive bladder using antimuscarinic treatment. BJU Int. 2006;97(3) :540-546. Doi:10. 1111/j.1464-410X.2006.06035.x.
- https://www.who.int/ru/news/item/30-09-2015-who-number-of-people-over-60-years-set-to-double-by-2050-major-societal-changes-required
- Milsom I., Coyne K.S., Nicholson S., Kvasz M, Chen C.I., Wein A.J. Global prevalence and economic burden of urgency urinary incontinence: a systematic review. Eur Urol. 2014;65(1):79-95. Doi: 10.1016/j. eururo.2013.08.03.1
- Штульман Д.Р., Левин О.С. Умеренные когнитивные нарушения... Справочник практического врача. 4-е изд. М.: Медпресс-информ, 2005
- Callegari E., Malhotra B, Bungay PJ, Webster R, Fenner KS, Kempshall S, LaPerle JL, Michel MC, Kay GG. A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder. Br J Clin Pharmacol. 2011 ;72(2):235-246. doi: 10.1111/j.1365-2125.2011.03961.x
- Коршунова Е.С., Коршунов М.Н. Гиперактивный мочевой пузырь у мольтиморбидных больных. Что нужно помнить? Consilium Medicum. 2018;20(7):41-45
- Geller E.J., Crane A.K., Wells E.C., et al. Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in postmenopausal women. Clin Drug Investig. 2012;32(10):697-705. doi: 10.2165/11635010 000000000-00000
- Staskin D., Kay G., Tannenbaum C., Goldman H.B., Bhashi K., Ling J., Oefelein M.G.Trospium Chloride Has No Effect on Memory Testing and Is Assay Undetectable in the Central Nervous System of Older Patients with Overactive Bladder. Int J Clin Pract 2010;64:1294-1300. doi: 10.1111/j.1742-1241.2010.02433.x
- Araklitis G., Robinson D., Cardozo L. Cognitive Effects of Anticholinergic Load in Women with Overactive Bladder. Clinical Interventions in Aging 2020;15:1493-1503. doi: 10.2147/CIA.S252852
- Ivchenko A., Bodeker R.H., Neumeister C. et al. Anticholinergic burden and comorbidities in patients attending treatment with trospium chloride for overactive bladder in a real-life setting: results of a prospective noninterventional study. BMC Urol. 2018;18(80). Doi.org/10.1186/s12894 018-0394-8
- Zaharova M.N. et al. Multiple sclerosis: issues of diagnosis and treatment. M., Media Mente. 2018. 240 p. Russian (Захарова М.Н. и соавт. Рассеянный склероз: вопросы диагностики и лечения. М., Медиа Менте. 2018. 240 с. ISBN 978-5-9907487-9-8).
- Guay D.R.P. Clinical pharmacokinetics of drugs used to treat urge incontinence. Clin Pharmacokinet. 2003;42:1243-1285. doi: 10.2165/00003088-200342140-00004.
- Ohtake A., Saitoh C., Yuyama H. Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents. Biol Pharm Bull. 2007;30:54-58. Doi: 10.1248/ bpb.30.54.
- Chapple C.R., Khullar V., Gabriel Z. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol. 2008;54:543-562. doi: 10.1016/j.eururo.2008.06.047.
- Ortiz de Montellano, Paul R. Cytochrome P450: structure, mechanism, and biochemistry. 3rd edition. New York: Kluwer Academic/Plenum Publishers, 2005. ISBN 0-306-48324-6.
- Crewe H.K., Lennard M.S., Tucker G.T. The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. 1992/09/01 ed. Br J Clin Pharmacol. 1992;34:262-265.
- Yaich M., Popon M., Medard Y. In-vitro cytochrome P450 dependent metabolism of oxybutynin to N-deethyloxybutynin in humans. Pharmacog enetics.1998;8(5):449-451.